Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
What is RAVICTI
1.3% and 1.9% of patients in the 9 mg and 25 mg semaglutide group, respectively, reported moderate-severe non-proliferative diabetic retinopathy events, and 0% and 0.4% reported proliferative retinopathy events, respectively
Nutrient facts may not be correct
It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are primarily used in the treatment of type 2 diabetes
3 Biotech 16 , 312 (2026)
US$ 21.38
US$ 22.69
US$ 26.41
US$ 22.29
US$ 21.85
US$ 21.20
US$ 22.72
US$ 27.83
US$ 20.80
US$ 27.10
